Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641912 · ClinicalTrials.gov registry record · NA
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
A NA study of Xerostomia, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02641912 is a NA study of Xerostomia that has completed, run by GlaxoSmithKline. The registered enrollment target is 100 participants, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02641912, a NA study of Xerostomia, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a single center, 7-day, examiner blind, two treatment-arm, randomized, stratified (Sjogren's Syndrome status \[Y/N\]), parallel group study conducted in participants experiencing dry mouth symptoms. This study is designed to investigate the effect of an experimental mouthwash formulation in providing relief of dry mouth symptoms.
Conditions Studied
Interventions
- OTHER Biotene mouthwash
- OTHER Mineral Water
Study Locations (1)
Massachusetts
- GSK Investigational Site - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-03-09 |
| Est. Completion | 2016-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641912
The ClinicalTrials.gov registry entry for NCT02641912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 2 interventions - of which Biotene mouthwash is the first listed.
NCT02641912 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02641912 about?
NCT02641912 is a clinical study titled "Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms". This will be a single center, 7-day, examiner blind, two treatment-arm, randomized, stratified (Sjogren's Syndrome status \[Y/N\]), parallel group study conducted in participants experiencing dry mouth symptoms. This study is designed to investigate the effect of an experimental mouthwash formulatio...
What is the current status of trial NCT02641912?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-03-09. Estimated completion is 2016-04-15.
What conditions does trial NCT02641912 study?
This clinical trial studies the following conditions: Xerostomia.
What interventions are being tested in trial NCT02641912?
The interventions under investigation include: Biotene mouthwash (OTHER), Mineral Water (OTHER).
Who is sponsoring clinical trial NCT02641912?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02641912 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
SaliPen Human Factors Study for OTC Labeling
COMPLETED · NA
-
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
COMPLETED · NA
-
Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray
COMPLETED · NA
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
RECRUITING · Phase 1
-
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.